Molecular Hydrogen Therapy Enhances Immune Markers in Treg, Plasma, Tr1 Cells, and KLRG1 Expression on Tc Cells: A Case of Acute SDH With Midline Shift and Uncal Herniation Post-decompressive Craniectomy.
Hui-Fu Hsu, Ruei-Yang Hu, Jeng-Wei Lu, Dueng-Yuan Hueng, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Kuang-Yih Wang, Hsiao-Chen Liu, Feng-Cheng Liu · In vivo (Athens, Greece) · 2025
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The researchers administered hydrogen capsules as a novel adjunct therapy, beginning daily treatment immediately upon admission. These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence inflammatory regulation.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen affected the outcomes measured in It may also protect mitochondria, support cell function, and regulate immune responses, making it a promising new treatment option for SDH. The researchers administered hydrogen capsules as a novel adjunct therapy, beginning daily treatment immediately upon admission.
What the Researchers Studied
The researchers studied It may also protect mitochondria, support cell function, and regulate immune responses, making it a promising new treatment option for SDH.
What Effects Did Molecular Hydrogen Have?
The researchers administered hydrogen capsules as a novel adjunct therapy, beginning daily treatment immediately upon admission. The authors concluded that this case suggests that molecular hydrogen therapy may be a helpful adjunct treatment for SDH with midline shift.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential to influence inflammatory regulation and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a case report. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as case report with human clinical evidence. The research population or model was It may also protect mitochondria, support cell function, and regulate immune responses, making it a promising new treatment option for SDH.
Limitations and Safety
No separate limitations or safety findings were identified in the source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.